Kickstart drug repurposing: smashing the roadblocks on the route to patients
How LifeArc aims to support charities, researchers and funders exploring new uses for existing medicines
LifeArc’s Opportunity Assessment Group (OAG) team played a vital role in supporting the UK’s #COVID19 #Theraputics… https://t.co/qkgycA5TOe
Proud to be part of the scientific community driving MND research
The status of scientific understanding of MND and the ambition behind creating the joint fund with the MND Association
Repurposing drugs: the opportunity and the challenges
Catriona Crombie outlines the case studies from our seminar on drug repurposing
The pandemic – a driving force for innovation in diagnostics?
Ciaran Fulton, Head of Diagnostics, reflects on the rapid evolution of diagnostics during the pandemic.
International Women’s Day 2021 – salute to women trailblazing innovation
Anji Miller, Senior Business Manager and advocate for diversity, discusses representation in science for International Women's Day 2021.
Celebrating UN International Day of Women and Girls in Science 2021
At a time when the world is looking to science for the answers, LifeArc marks the UN’s…
LifeArc marks Rare Disease Day 2020 with a call for more translational research
Translational research can turn promising science into new treatments for those with rare diseases. It’s why we…
Celebrating the International Day of Women and Girls in Science
LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that hold women back.
Alliance enables clinical trial of experimental treatment for epidermolysis bullosa
An experimental medicine to treat the rare inherited skin disorder epidermolysis bullosa (EB) is on track to start trials in patients thanks to the perseverance of the charity team at LifeArc.